HPTN083 Clinical Physician
We have been conducting HPTN 083, a clinical trial to evaluate the safety and efficacy of the injectable agent, cabotegravir (CAB LA), for pre-exposure prophylaxis (PrEP) in HIV-uninfected cisgender men and transgender women who have sex with men (MSM and TGW). This study will be implemented in 5 years. We are now seeking a talented, dedicated and committed individual to join our team with the position of HPTN083 Clinical Physician working at study site/Yen Hoa Health Clinic, Cau Giay Health District, Hanoi. This study is conducted by The University of North Carolina (UNC), Hanoi Medical University in a cooperation with the 198 Hospital. The study site for participant recruitments based in Yen Hoa Health Clinic of Cau Giay Health District Center.
Please find the attached TOR [1] for more details.
Interested cadidates should send applications to [email protected] [2]
Deadline for application: 17.00, 14/12/2018.